ImmunoPrecise Antibodies Ltd. (IPA)
NASDAQ: IPA · Real-Time Price · USD
0.4501
+0.0012 (0.27%)
At close: May 12, 2025, 4:00 PM
0.4500
-0.0001 (-0.02%)
After-hours: May 12, 2025, 6:10 PM EDT
ImmunoPrecise Antibodies Market Cap
ImmunoPrecise Antibodies has a market cap or net worth of $20.60 million as of May 12, 2025. Its market cap has decreased by -35.83% in one year.
Market Cap
20.60M
Enterprise Value
20.61M
1-Year Change
-35.83%
Ranking
Category
Stock Price
$0.45
Market Cap Chart
Since December 31, 2020, ImmunoPrecise Antibodies's market cap has decreased from $250.60M to $20.60M, a decrease of -91.78%. That is a compound annual growth rate of -43.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 14.80M | 32.14% |
| Dec 31, 2024 | 11.20M | -73.83% |
| Dec 29, 2023 | 42.80M | -67.05% |
| Dec 30, 2022 | 129.90M | 25.14% |
| Dec 31, 2021 | 103.80M | -58.58% |
| Dec 31, 2020 | 250.60M | - |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.08B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |